Pharmacy Times

JULY 22, 2025

Alixorexton presents as a hopeful, potentially paradigm-shifting treatment for this population. In a sign of alixorexton’s tolerability, over 95% of patients who participated in this portion of the trial elected to join the ongoing 7-week, open-label extension.

Compounding Pharmacies 73

Compounding Pharmacies Immunization Hospitals Compounding 73

Pharmacy Times

JUNE 23, 2025

Additionally, ANDA submissions should extrapolate the RLD safety and effectiveness data for drugs with the same active ingredients, dosage forms, strengths, routes, and labeling. Presented at: Hematology/Oncology Pharmacy Association 2025 Annual Conference; April 9-12, 2025; Portland, OR. REFERENCE Soefje SA.

FDA 65

FDA Compounding Pharmacies Dosage Hospitals 65

Pharmacy Times

JULY 22, 2025

This change mirrored a January 2025 FDA safety alert and label update that urged providers to consider genetic testing, inform patients of the risks, and discuss available options. Demonstrating improved outcomes and cost-effectiveness helps ensure payer support and broadens access to precision therapies.

Compounding Pharmacies 50

Compounding Pharmacies FDA Hospitals Immunization 50

Pharmacy Times

JULY 7, 2025

Limitations included open-label design and dosage constraints, but the multicountry approach enhanced generalizability and external validity. 1 “The limitations of this study were it being open-label, allowing potential assessment biases and the absence of blinded assessment of clinical endpoints. Additionally, SOCs with at least 2.5%

Compounding Pharmacies 98

Compounding Pharmacies Dosage Labelling Immunization 98

Pharmacy Times

JUNE 23, 2025

Because these conditions are linked—sustained hypertension may contribute to impaired kidney function, and progressive decrease in kidney function may lead to worsening blood pressure control—the risk of cardiovascular disease and mortality rises significantly when CKD is present in patients with hypertension.

Compounding Pharmacies 129

Compounding Pharmacies Immunization Hospitals Compounding 129

Pharmacy Times

JUNE 30, 2025

The findings from a phase 2 study (NCT04988815) were presented at the 2025 American Society of Clinical Oncology Annual Meeting in Chicago. 2-5 In the multicenter, phase 2, open-label prospective study, researchers investigated ropeg-IFN-α2b treatment in patients with profibrotic MF or DIPSS low-intermediate-1 risk MF. FiercePharma.

Compounding Pharmacies 86

Compounding Pharmacies Immunization Compounding Specialty Pharmacies 86

Pharmacy Times

JUNE 23, 2025

The presentation emphasized early intervention and personalized treatment plans in managing type 2 diabetes, shifting from "treating to failure" to "treating to target." Presented: 85th Scientific Sessions of the American Diabetes Association; June 23, 2025; Chicago, Illinois. 1 REFERENCES 1. Pharmacy Times Staff.

HIV Treatment and Prevention Agents 81

HIV Treatment and Prevention Agents Compounding Pharmacies Immunization FDA 81

Pharmacy Times

JULY 18, 2025

1 STARGLO is an open-label, multicenter, randomized phase 3 STARGLO clinical trial which compared the efficacy and safety of glofitamab and GemOx (Glofit-GemOx) with rituximab (Rituxan; Genentech) and GemOx (R-GemOx) in patients with R/R DLBCL who have received at least 2 prior lines of treatment.

FDA 65

FDA Compounding Pharmacies Immunization Hospitals 65

Pharmacy Times

JUNE 9, 2025

2 However, Dalton noted that some procedures can change once a treatment is FDA-approved, with complications from Risk Evaluation and Mitigation Strategy programs as well as the occasional surprise on an FDA label. Presented at: American Society of Health-System Pharmacists 2025 Pharmacy Futures. Updated March 20, 2023.

Compounding Pharmacies 56

Compounding Pharmacies FDA Hospitals Immunization 56

Pharmacy Times

JUNE 9, 2025

These findings, which were presented at the 2025 American Society of Clinical Oncology in Chicago, Illinois, suggest that omitting carboplatin from treatment regimens could be an efficacious de-escalated neoadjuvant strategy in this patient population. If caught early, the cancer can often be treated and cured, according to Cleveland Clinic.

Compounding Pharmacies 65

Compounding Pharmacies Hospitals Immunization Compounding 65

PharmTech

JUNE 12, 2025

Image Credit: © Tada Images - stock.adobe.com In a June 10, 2025 update, FDA posted seven updated Warning Letters, issued between the beginning of 2025 and the present, to its online database, which stores more than 3400 such letters dating back to 2020 (1). American Behavioral Research Institute Boca Raton, Fla. –

FDA 59

FDA Dosage Compounding Labelling 59

Pharmacy Times

JUNE 30, 2025

The data from an ongoing phase 1 LIMBER trial (NCT04279847) were presented at the 2025 American Society of Clinical Oncology Annual Meeting in Chicago. Thus, researchers are investigating the clinical benefit of INCB057643 in combination with Janus kinase (JAK) inhibitors, a cornerstone of MF treatment. Subscribe Now!

Compounding Pharmacies 65

Compounding Pharmacies Compounding Immunization Specialty Pharmacies 65

Drug Topics

JUNE 25, 2025

Despite a high prevalence of childhood and youth-aged obesity, the use of medications for treating obesity is persistently low among children and young adults (YA), according to an abstract presented at the American Diabetes Association’s 85th Scientific Sessions, held in Chicago, Illinois, from June 20-23, 2025. of adolescents and 5.7%

Compounding 315

Compounding Insurance Coverage Insurance Specialty Pharmacies 315

Drug Topics

JUNE 26, 2025

1 Data from the study were presented at the American Diabetes Association’s 85th Scientific Sessions, which were held June 20-23 in Chicago, Illinois. 1 Data from the study were presented at the American Diabetes Association’s 85th Scientific Sessions, which were held June 20-23 in Chicago, Illinois. News Release. Corcept Therapeutics.

Compounding 315

Compounding Specialty Pharmacies Independent Pharmacies Insurance 315

Pharmacy Times

JUNE 20, 2025

In general, choosing a product that has broad spectrum on the label, covering both UV-A and UV-B rays and containing 20% zinc oxide, for her children will be optimal, especially for more sensitive areas of the skin. 4,5 CASE 4 Treating Insect Bites AK is an 18-year-old man presenting with pruritic lesions on his arms and legs.

Compounding Pharmacies 97

Compounding Pharmacies Immunization FDA Hospitals 97

Pharmaceutical Commerce

JULY 16, 2025

1 In response to this immense demand, coupled with high costs and accessibility issues, compounded alternatives have emerged as a seemingly pragmatic solution. However, these compounded GLP-1s are creating a significant, often underestimated, legal, reputational, and financial minefield for startups and the broader life sciences industry.

Compounding 69

Compounding Insurance FDA Compounding Pharmacies 69

The Thyroid Pharmacist

MARCH 7, 2025

to fluoride in my tap water, to hidden mold in my home, to my shampoo and deodorant (have you ever read those labels?!), These reactions are often due to the toxic backlog that is present in their body, which can cause them to react to everything in their environment as well. From indoor pollutants like formaldehyde (yes, really!),

Health and Personal Care Stores 67

Health and Personal Care Stores Labelling Immunization Packaging 67

The Thyroid Pharmacist

MAY 15, 2025

Higher levels of bad bacteria and lower levels of beneficial bacteria can contribute to the development of leaky gut , which we know is one of three things that must be present in order for autoimmune disease to develop (in addition to a genetic predisposition and an environmental trigger). [4]

Immunization 59

Immunization Compounding Labelling 59

Pharmacy Times

JUNE 9, 2025

The findings were presented at the 2025 American Society of Clinical Oncology Annual Meeting, which was held in Chicago, Illinois. The findings were presented at the 2025 American Society of Clinical Oncology Annual Meeting, which was held in Chicago, Illinois. months versus 2.1

Compounding Pharmacies 73

Compounding Pharmacies Immunization Hospitals Compounding 73

Pharmacy Times

JUNE 15, 2025

In the randomized, open-label, multicenter phase 3 NATALEE clinical trial (NCT05306340), ribociclib (Kisqali; Novartis) plus endocrine therapy, a nonsteroidal aromatase inhibitor (NSAI), significantly improved invasive disease-free survival among individuals with HR-positive (HR+) and HER2-negative (HER2-) early breast cancer.

Mayo Clinic 106

Mayo Clinic Compounding Pharmacies Immunization Compounding 106

Drug Topics

JUNE 17, 2025

By acting on hair follicle stem cells—which remain present even in balding areas—PP405 offers a promising option for people often left out by existing therapies. After the randomized portion of the study, patients were eligible to enroll in an open-label extension study for 3 months to assess the long term safety of PP405.

Specialty Pharmacies 324

Specialty Pharmacies Compounding Independent Pharmacies Immunization 324

Pharmacy Times

JULY 21, 2025

It remains active in tumors that have developed resistance to first-, second-, and third-generation ALK inhibitors, including tumors with single or compound treatment-emergent ALK mutations. J Clin Oncol. 2025;43(Number 16_suppl). doi:10.1200/JCO.2025.43.16_suppl.TPS8666 2025.43.16_suppl.TPS8666 Nuvalent Investors. News release.

Compounding Pharmacies 50

Compounding Pharmacies Compounding FDA Immunization 50

Pharmaceutical Technology

JULY 10, 2025

Ross Law July 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The global oncology market is set to grow at a compound annual growth rate (CAGR) of 24.5%. Image credit: CI Photos / Shutterstock. Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

Packaging 52

Packaging Compounding Hospitals Communication 52

Hospital Pharmacy Europe

JANUARY 16, 2025

A new global study from the International Pharmaceutical Federation (FIP)s Pediatric Formulations Focus Group is the first to report current and global paediatric oral extemporaneous compounding practices. Other reasons for widespread off-label prescribing include the high development cost and complexity in paediatric drug development.

Compounding 119

Compounding Labelling Dosage Hospitals 119

IDStewardship

OCTOBER 14, 2024

Read all about this in the product label here. More information on ganciclovir in the label here. Compounding sulbactam-durlobactam Admittedly I have never compounded this one myself, but it just sounds like an error waiting to happen as well as a considerable time commitment. Well, maybe not. Have another one?

Compounding 130

Compounding Labelling Packaging Hospitals 130

The Checkup by Singlecare

JANUARY 6, 2025

It is also prescribed off-label for weight loss. Compounded semaglutide is a medication thats custom-made for you by a compounding pharmacy. Though sometimes marketed as a generic version of Ozempic , compounded versions of semaglutide are not FDA approved. RELATED: Is compounded semaglutide safe?

Compounding 52

Compounding Compounding Pharmacies FDA Dosage 52

pharmaphorum

DECEMBER 5, 2022

A vast majority of patients diagnosed with CRPC already present with metastases at the time of diagnosis. The findings will be presented at an upcoming medical meeting and submitted to the FDA for regulatory approval in 2023. Prostate cancer is the most frequently diagnosed cancer in men in 112 countries.

Chemotherapy 59

Chemotherapy Compounding Labelling FDA 59

European Pharmaceutical Review

JANUARY 23, 2023

In addition, MSSG supports temporary national measures such as unit dose dispensing and compounding. MSSG and the SPOC working party will continue to closely monitor the situation together with the EC and EU States.

Packaging 98

Packaging Compounding Labelling Communication 98

Pharmaceutical Technology

JULY 26, 2022

The three major markets (3MM: the US, Germany and the UK) will increase in market size from $128.35m last year to $188.35m in 2031, at a compound annual growth rate (CAGR) of 3.9%. This sales growth will be in line with a steadily increasing disease prevalence and the entrance of novel agents into the market.

Compounding 122

Compounding Labelling 122

Hospital Pharmacy Europe

FEBRUARY 8, 2024

These will undoubtedly present great opportunities for hospital pharmacists and their teams. We have just stepped into a new year, and it is already clear that the pharmacy landscape is set to experience significant innovations and challenges over the coming weeks and months.

Hospitals 111

Hospitals Health and Personal Care Stores Medical Records Compounding 111

The Checkup by Singlecare

SEPTEMBER 24, 2024

The natural caffeine and B vitamins present in kombucha may help combat that mid-morning slump,” Manaker explains. Generally speaking, though, Gaw says the amount of alcohol present in one serving of kombucha is usually not enough to cause this sensation. thanks to its high content of probiotics, vitamins, and minerals, notes Gaw.

Health and Personal Care Stores 111

Health and Personal Care Stores Labelling Compounding 111

BuzzRx

OCTOBER 21, 2022

Remember that iron is present as a food additive in many foods like cereals. How to read iron supplement labels? If you have iron deficiency anemia and are taking iron supplements to get enough iron, you will notice that there are two amounts indicated on the label. The 325 mg refers to the ferrous sulfate compound.

Compounding 52

Compounding Labelling 52

Pharmaceutical Technology

JANUARY 23, 2023

Therefore, with an inadequate or loss of response to these anti-TNFs, clinicians must prescribe adult therapies off-label to treat younger patients. This lack of options and progression within this IBD patient subpopulation presents a clear unmet need and opportunity.

Compounding 59

Compounding Labelling FDA 59

The FDA Law Blog

JULY 5, 2023

As a reminder, in Title I of the 2013 Drug Quality and Security Act (DQSA) (the Compounding Quality Act), Congress created the “outsourcing facility” FDA registration category, and set forth statutory parameters for their operation in new section 503B of the FDCA. See 21 U.S.C. 353b(a)(8). 353b(a)(8).

Compounding 52

Compounding FDA Hospitals Labelling 52

Pharmaceutical Technology

DECEMBER 16, 2022

The endometriosis market is expected to grow from $1.05bn in 2020 to $2.72bn in 2030 at a compound annual growth rate (CAGR) of 10.0% The shrinking female population ages 12–54 years in the 5EU and Japan will dampen the extent of growth in diagnosed endometriosis cases.

Compounding 59

Compounding Labelling 59

The Checkup by Singlecare

FEBRUARY 2, 2024

Dr. Williams notes that the research also suggests that chlorophyllin needs to be present along with the carcinogen in order to be really effective. Currently, there’s no recommended daily allowance, but product labels may recommend drinking 100–200 milligrams daily, depending on the product.

Compounding 98

Compounding Labelling Packaging 98

The Checkup by Singlecare

OCTOBER 10, 2024

Ozempic (semaglutide) is the breakout diabetes drug that has seen widespread, off-label use as a weight loss drug. Ozempic half-life: Why it matters The half-life of a drug is the timeframe in which half of the compound is eliminated from the body after a dose. Health insurance plans often deny coverage for drugs used off-label.

Labelling 52

Labelling Insurance Dosage FDA 52